Soluble human CD4 elicits an antibody response in rhesus monkeys that inhibits simian immunodeficiency virus replication
- Harvard Medical School, Southborough, MA (United States)
Rhesus monkeys infected with the simian immunodeficiency virus of macaques (SIV{sub mac}) demonstrate significant virologic and clinical improvement as a result of treatment with human recombinant soluble CD4 (rsCD4). The authors show that human rsCD4 does not efficiently inhibit SIV{sub mac} replication in bone marrow macrophages of rhesus monkeys and does not significantly augment bone marrow hematopoietic colony formation in vitro. However, plasma of human rsCD4-treated rhesus monkeys does exhibit significant anti-SIV{sub mac} activity in vitro. Plasma of these animals efficiently blocks SIV{sub mac} replicaton in peripheral blood lymphocytes and bone marrow macrophages. It also increases granulocyte/macrophage colony formation in vitro by bone marrow cells of SIV{sub mac}-infected monkeys. This plasma and the IgG fraction of plasma from a rhesus monkey immunized with human rsCD4 in adjuvant demonstrate reactivity with a soluble form of the rhesus monkey CD4 molecule, exhibit binding to CD4{sup +} but not CD8{sup +} concanavalin A-activated rhesus monkey peripheral blood lymphocytes, and precipitate the CD4 molecule from surface-labeled activated rhesus monkey peripheral blood lymphocytes. Moreover, anti-viral activity is demonstrable in the IgG fraction of plasma from a human rsCD4-immunized monkey. These studies raise the possibility that a modified human CD4 molecule serving as an immunogen might elicit an antibody response that could potentially induce a beneficial therapeutic response in human immunodeficiency virus-infected individuals.
- OSTI ID:
- 5079671
- Journal Information:
- Proceedings of the National Academy of Sciences of the United States of America; (United States), Vol. 88:1, Issue 1; ISSN 0027-8424
- Country of Publication:
- United States
- Language:
- English
Similar Records
Complex assembly, crystallization and preliminary X-ray crystallographic studies of rhesus macaque MHC Mamu-A*01 complexed with an immunodominant SIV-Gag nonapeptide
Partial protection of SIV-infected rhesus monkeys against superinfection with a heterologous SIV isolate
Related Subjects
AIDS VIRUS
IMMUNOLOGY
RECEPTORS
BIOCHEMISTRY
BONE MARROW CELLS
CELL FLOW SYSTEMS
GLYCOPROTEINS
IMMUNOGLOBULINS
MACROPHAGES
MONKEYS
MONOCLONAL ANTIBODIES
ANIMAL CELLS
ANIMALS
ANTIBODIES
CHEMISTRY
CONNECTIVE TISSUE CELLS
GLOBULINS
MAMMALS
MEMBRANE PROTEINS
MICROORGANISMS
ORGANIC COMPOUNDS
PARASITES
PHAGOCYTES
PRIMATES
PROTEINS
SOMATIC CELLS
VERTEBRATES
VIRUSES
550201* - Biochemistry- Tracer Techniques